Similar articles

• Electrocardiography for left ventricular hypertrophy in hypertension: time for re-evaluation?

  Schillaci G, Verdecchia P, Pede S, Porcellati C. Schillaci G, et al. G Ital Cardiol. 1998 Jun;28(6):706-13. G Ital Cardiol. 1998. PMID: 9672786 Review. No abstract available.
• Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study.

  Li Z, Dahlöf B, Okin PM, Kjeldsen SE, Wachtell K, Ibsen H, Nieminen MS, Jern S, Devereux RB. Li Z, et al. J Hypertens. 2008 Jun;26(6):1244-9. doi: 10.1097/HJH.0b013e3282fcc23c. J Hypertens. 2008. PMID: 18475164 Clinical Trial.
• Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).

  Okin PM, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Nieminen MS, Edelman JM, Dahlöf B, Devereux RB; LIFE Study Investigators. Okin PM, et al. Circulation. 2009 Apr 14;119(14):1883-91. doi: 10.1161/CIRCULATIONAHA.108.812313. Epub 2009 Mar 30. Circulation. 2009. PMID: 19332468 Clinical Trial.
• [Arterial hypertension, left ventricular hypertrophy and cardiovascular risk].

  Nogueira JB. Nogueira JB. Acta Med Port. 1995 Dec;8(12):663-6. Acta Med Port. 1995. PMID: 8669314 Review. Portuguese. No abstract available.
• [Electrocardiographic findings in hypertension].

  Ueno H, Inoue H. Ueno H, et al. Nihon Rinsho. 2004 Mar;62 Suppl 3:296-300. Nihon Rinsho. 2004. PMID: 15171387 Review. Japanese. No abstract available.